[PRESENT POSSIBILITIES OF CYTOCHEMOTHERAPY AND INTRACAVITARY ISOTOPE THERAPY IN EXTENSIVE SEROUS EFFUSIONS OF NEOPLASTIC ORIGIN. CLINICAL EXPERIENCES WITH AU 198 AND 2,3,5-TRIETHYLENEIMINO-BENZOQUINONE].
D000970:Antineoplastic Agents; D016227:Benzoquinones; D004358:Drug Therapy; D005260:Female; D006049:Gold Isotopes; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D010051:Ovarian Neoplasms; D010166:Palliative Care; D014116:Toxicology
D000970:Antineoplastic Agents; D016227:Benzoquinones; D006049:Gold Isotopes
ANTINEOPLASTIC AGENTS; DRUG THERAPY; GOLD ISOTOPES; NEOPLASM RADIOTHERAPY; OVARIAN NEOPLASMS; PALLIATIVE TREATMENT; TOXICOLOGIC REPORT
POSSIBILIT'A ATTUALI DELLA CITOCHEMIOTERAPIA E DELLA ISOTOPOTERAPIA ENDOCAVITARIA NEI GRANDI VERSAMENTI SIEROSI DI ORIGINE NEOPLASTICA. ESPERIENZE CLINICHE CON L'AU198 E CON IL 2,3,5-TRIETILENIMINO-BENZOCHINONE.